NC
AGN

Northpointe Capital’s Allergan plc AGN Stock Holding History

Northpointe Capital’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-38,586
Closed -$5.65M – 112
2019
Q1 		$5.65M Buy
+38,586
New +$5.59M 1.78% 11
2014
Q4 		– Sell
-6,688
Closed -$1.61M – 270
2014
Q3 		$1.61M Buy
+6,688
New +$1.5M 0.17% 160

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
LP
Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Northpointe Capital's AGN Position: Q2 2019 in Review

Northpointe Capital sold out of Allergan plc (AGN) in Q2 2019, closing a stake of 38,586 shares — an estimated $5.65M sold.

Northpointe Capital first reported a position in AGN in Q3 2014 and held it in 2 quarters. The position peaked at $5.65M in Q1 2019. 970 funds tracked by Wall St. Rank hold AGN as of Q2 2019.

  • Northpointe Capital reported no remaining Allergan plc position as of Q2 2019 after selling out during the quarter.
  • Northpointe Capital sold 38,586 Allergan plc shares in Q2 2019, an estimated $5.65M.
  • Northpointe Capital first reported a position in Allergan plc in Q3 2014 and held it in 2 quarters.
  • Northpointe Capital's Allergan plc position peaked at $5.65M in Q1 2019.
  • 970 funds tracked by Wall St. Rank held Allergan plc as of Q2 2019.

Based on Northpointe Capital's 13F filing for Q2 2019, filed 26 Jul 2019.